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This is 1 of 5 articles generated from the SETAC Pellston Workshop “Ecotoxicological Hazard and Risk Assessment
Approaches for Endocrine-Active Substances (EHRA)” (February 2016, Pensacola, Florida, USA). The primary aim of the
workshop was to provide objective advice, based on current scientific understanding, to regulators and policy makers,
whether in industry, government, or academia. The goal is to make considered, informed decisions on whether to select
an ecotoxicological hazard- or risk-based approach for regulating a given endocrine disrupting substance under
evaluation.ABSTRACT
Endocrine-disrupting substances (EDS)may have certain biological effects includingdelayedeffects,multigenerational effects,
and may display nonmonotonic dose–response (NMDR) relationships that require careful consideration when determining
environmental hazards. Endocrine disrupting substances can have specific and profound effects when exposure occurs during
sensitive windows of the life cycle (development, reproduction). This creates the potential for delayed effects that manifest when
exposurehas ceased, possibly in adifferent life stage. This potential underscores theneed for testing in appropriate (sensitive) life
stages and full life cycle designs. Such tests are available in the Organisation for Economic Co-operation and Development
(OECD) tool box and should be used to derive endpoints that can be considered protective of all life stages. Similarly, the
potential for effects to bemanifest in subsequent generations (multigenerational effects) has also been raised as a potential issue
in the derivation of appropriate endpoints for EDS. However, multigenerational studies showing increasing sensitivity of
successive generations are uncommon. Indeed this is reflected in the design of new higher tier tests to assess endocrine active
substances (EAS) that move to extended one-generation designs and away from multi-generational studies. The occurrence of
NMDRs is also considered a limiting factor for reliable risk assessment of EDS. Evidence to date indicates NMDRs are more
prevalent in in vitro andmechanistic data, not often translating to adverse apical endpoints thatwould be used in risk assessment.
A series of steps to evaluate NMDRs in the context of endocrine hazard and risk assessment procedures is presented. If careful
consideration of delayed,multigenerational effects andNMDRs ismade, it is feasible to assess environmental endocrine hazards
and derive robust apical endpoints for risk assessment procedures ensuring a high level of environmental protection. Integr
EnvironAssessManag2017;13:293–301.C 2016TheAuthors. IntegratedEnvironmentalAssessment andManagementpublished
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In recent years, endocrine disruption has become a topic of
increasing public and regulatory concern. Consequently,
policies and legislation in the major regions have been
implemented to regulate endocrine-disrupting substancesC 2016 The Authors/ieam.1866
294 Integr Environ Assess Manag 13, 2017—JL Parrott et al.(EDS). However, these regulations have become divergent in
the approaches proposed. In the United States and Japan,
programs such as the Endocrine Disruptor Screening
Program (EDSP) (USEPA 1998) and Extend (Ministry of the
Environment Japan 2010) are in place to identify endocrine
activity. Where necessary, these programs lead to higher tier
testing to define concentration–response relationships,
perform risk assessment, and conclude on the risk that EDS
present to the environment. In Europe, hazard-based cutoff
(ineligibility for registration) criteria for EDS are being
implemented in some legislations. Most of the cited scientific
reasons used to support regulation based solely on hazard
center around uncertainties in describing the biological
responses of EDS. These are properties, although not
exclusive to endocrine-active substances (EAS), which are
potentially problematic for the robust derivation of no
observed adverse effect levels (NOAELs) required for sound
risk assessment. Endocrine-active substances may exhibit
delayed or multigenerational effects where an effect is not
necessarily manifest at the time of exposure but in a different
life stage or generation. Thesephenomena are discussed and
linked to the need for appropriate use of specific ecotoxico-
logical tests from the tool box described by the Organisation
for Economic Co-operation and Development (OECD)
Conceptual Framework for Testing and Assessment of
Endocrine Disrupters (OECD 2012). Similarly, the presence
of nonmonotonic dose–response (NMDR) relationships has
clouded the toxicological paradigm for EDS. This controver-
sial issue (Rhomberg and Goodman 2012; Vandenberg et al.
2012) continues to be investigated by exhaustive data
reviews (National Research Council 2014). Here, we discuss
NMDR occurrence and their relation to adversity, and
propose a way forward to assess and incorporate NMDRs
into test and assessment strategies.
DELAYED EFFECTS
Delayed effects are a feature of many EAS and they occur
when exposure coincides with sensitive windows in the life
cycle, yet the effects are seen later on. In such cases, the
morphological changes that arise can have severe, lasting
consequences even if exposure ceases. Here, we define
delayed effects as dose–concentration-dependent effects
induced by exposure during critical windows of develop-
ment or reproduction, which become observable only
later on during the life cycle (in another development
stage or even in the next generation) after exposure has
ceased. This excludes certain effects that may appear later
in long term tests as a result of toxicodynamic-toxicokinetic
factors.
The case studies developed for the SETAC Pellston
Workshop (Matthiessen et al. this issue) provide many
examples of delayed effects—particularly in fish species.
For example, exposure to potent estrogens such as
17a-ethinylestradiol (EE2) ( €Orn et al. 2003; Maack and
Segner 2004; Nash et al. 2004; Sch€afers et al. 2007;
Baumann et al. 2014), during the period of sexual
differentiation and gonadal development may result inIntegr Environ Assess Manag 2017:293–301 wileyonlinelibrary.cskewed sex ratios, and also, in some instances, lower
reproductive outcome in the adult stages. Feminisation
caused by exposure to estrogens is partly reversible (Maack
and Segner 2004; Sch€afers et al. 2007; Baumann et al.
2014), but some EE2 experiments show no recovery of egg
production or fertilization rate if exposure was during a
critical window (Nash et al. 2004; Xu et al. 2008).
Exposure to nonaromatizable androgens (that cannot be
converted to estrogens) during sexual differentiation is
known to masculinize fish. Zebrafish (Danio rerio) exposed
to trenbolone (TRB) during sexual differentiation develop
skewed sex ratios and all male populations at 0.01mg/L
and above (Larsen and Baatrup 2010; Morthorst et al.
2010; Boettcher 2011; Baumann et al. 2015) this pheno-
typic sex change is irreversible (Larsen and Baatrup 2010;
Morthorst et al. 2010; Baumann et al. 2015). The TRB-induced
reversal to a male phenotype appears more sensitive
in zebrafish than in medaka ( €Orn et al. 2006; Mizukami-
Murata et al. 2015). Other endocrine mechanisms can
also lead to masculinisation in fish (for a review see
Matthiessen and Weltje 2015). Piferrer et al. (1994) found
that genetically female Chinook salmon (Oncorhynchus
tshawytscha) developed into phenotypical males if briefly
exposed to the aromatase inhibitor fadrozole during sexual
differentiation.
These sex-reversal effects are not delayed per se, but may
be considered so, as we are able to measure them only at
later life stages (when the gonad is sufficiently developed for
histopathological examination). Furthermore, if the change is
irreversible, it is likely that a delayed population-level impact
may be observed, driven by an inappropriate sex ratio of
sexually mature individuals (see Supplemental Data S1 for
EE2 and Data S2 for TRB). However, it is important to
acknowledge that the typical measure of “sex reversal” is
often indirect. Most of the observations cited above are
based on phenotypic sex ratios (typically confirmed via
gonad histopathology) comparing treated and untreated
groups. It is assumed that statistically significant shifts in
phenotypic sex ratios are the result of sex reversal (i.e., the
proportion of genotypic sex was equal across treatments). Of
the commonly used fish test species, currently it is possible to
directly measure genotypic sex only in medaka where
comparisons of phenotypic versus genotypic sex (via DNA
sex probes) can truly be made.
In addition to fish, delayed effects of EDS are not
uncommon in the other vertebrate classes. Female Japanese
quail (Coturnix japonica) exposed in ovo to estrogens like
diethylstilbestrol (Kamata et al. 2006) and o,p0-DDT (Bryan
et al. 1989) lay eggs without shells due to abnormal oviductal
differentiation. In red-eared slider turtles (Trachemys scripta
elegans) that have temperature-dependent sex determina-
tion, in ovo exposure to 17b-estradiol (E2) can sex reverse
presumptive males (Sheehan et al. 1999). A wide range of
delayed adverse effects of EDS have also been reported in
mammalian reproduction studies (Gray and Kelce 1996). For
example, perinatal estrogen exposure has been shown to
alter gender-specific reproductive and nonreproductiveC 2016 The Authorsom/journal/ieam
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in females and shorten their reproductive life span (Gorski
1986).
Delayed effects can also be seen in invertebrate species
exposed to some EDS, such as juvenile hormone mimics
or ecdysone mimics. Exposure of larval honey bees
(Apis mellifera) to the juvenile hormone mimic fenoxycarb
on day 4 leads to lethal moults (no emergence of viable
adults) on day 22 (Aupinel et al. 2007). Similarly, the ecdysone
agonist insecticide tebufenozide, which was added on day 4
to a static aquatic test containing first-instar Chironomus
riparius larvae, led to lethal moults 3 weeks later (Hahn et al.
2001).
Overall for potent EDSactingon the hypothalamo-pituitary-
gonadal (HPG) axis, delayed effects in organisms are relatively
common (see Supplemental Data S1 for EE2 and Data S2 for
TRB). However, these effects are not unique toEDSas they can
often be related to exposure during developmental windows
similar to delayed effects from teratogens or developmental
neurotoxicants. To address this, many extended tests are
available in the OECD tool box (Coady et al. this issue). Using
these tests ensures that changes induced during critical
windowsof exposure are followed for longenough that effects
are seen, and thresholds for population-relevant apical
endpoints can be determined.
MULTIGENERATIONAL EFFECTS
Multigenerational effects can be described as effects seen
in the next generation and/or generations and can manifest
as an increased sensitivity of a following generation to the
test chemical. This may be caused by increased exposure,
where the second filial generation (F2) are exposed for longer
periods than the first filial generation (F1), or by exposure of
F2 over a sensitive window (during which the F1 were not
exposed). Multigenerational effects can also result after
parental generation (F0) or F1 exposure, where effects are
seen in F1/F2 offspring raised without exposure. However, it
should be acknowledged that there is also exposure of the F2
as gametes and in utero in the F1 organisms.
To assess the possibility of multigenerational effects of
EAS, study designs may include constant exposure to a
chemical over more than one generation, or shorter periods
in one generation, with targeted exposures to progeny over
critical developmental windows or with progeny reared
without exposure. Some evidence for such effects is reviewed
below.
Some studies have assessed multigenerational effects in
fish, where eggs from exposed F0 parents were hatched in
clean water. Although, exposure to gametes of the F0 that
give rise to the F1 is not excluded. Nash et al. (2004) studied
zebrafish eggs (from 0.5 and 4.5 ng/L EE2-exposed F0
parents) and saw no multigenerational effects on F1 or F2
embryos, larvae, or breeding success in the F1. Exposure of
rainbow trout (Oncorhynchus mykiss) F0 males to 0.8 ng/L
EE2 resulted in decreased survival of F1 offspring (Brown
et al. 2009). However, the surviving unexposedmale F1 trout,
whenmature (1 and 2 years old), were able to produce normalIntegr Environ Assess Manag 2017:293–301 DOI: 10.1002offspring. F1 threespined stickleback (Gasterosteus
aculeatus) exposed to high concentrations of sodium
perchlorate from fertilization to sexualmaturity (1 y) displayed
morphological abnormalities at concentrations greater than
or equal to 30mg/L; specifically, impaired formation of
calcified plates, fins, and spines (related to perchlorate’s
actions as a thyroid inhibitor) (Bernhardt et al. 2011).
However, surviving F2 raised in clean water for 25wk were
morphologically normal.
If studies have constant exposure over several generations,
multigenerational effects cannot be easily separated from
early-exposure effects. However, these types of constant-
exposure multigeneration studies can assess if there are
changes in sensitivity from one generation to the next (see
Supplemental Data S1 for EE2 andData S2 for TRB). A few fish
studies show no difference in effects from one generation to
the next. For example, F2 zebrafish embryo growth was
decreased by EE2 at similar exposure concentrations to F1
growth (Sch€afers et al. 2007). Similarly, Boettcher (2011) saw
no multigenerational effects of TRB on zebrafish F2 hatching
success or survival of eggs over 2 generations.
However, some fish multigenerational studies show
increasing effects and lower NOECs from subsequent
generations. F1 swim-up success of Chinese rare minnow
(Gobiocypris rarus) exposed to EE2 was negatively affected
at 0.91 ng/L, whereas parental F0 survival at swim-up
(exposed from egg stage) was not affected until 13.6 ng/L
(Zha et al. 2008). Fathead minnow (Pimephales promelas) F1
larval length and weight were decreased at 0.16 ng/L EE2,
whereas F0 length and weight were decreased at a higher
concentrations (12 ng/L) as they were exposed from the
fertilized egg stage only (L€ange et al. 2001). There is also
some evidence for increased effects of TRB over several
generations of exposure in fish. Cripe et al. (2010) conducted
a 3-generation flow-through study exposing sheepshead
minnow (Cyprinodon variegatus) to TRB. Reproduction was
significantly reduced at levels of 0.87, 0.027, and 0.027mg
TRB/L in the F0, F1, and F2 generations, respectively. The
differences in sensitivity may be related to exposure duration
and timing, where F0 were exposed from the adult stage
onward, whereas F1 and F2 were exposed in ovo and
throughout their lives (Cripe et al. 2010).
These studies provide evidence of some effects occurring
at lower concentrations in subsequent generations of fish
in comparison to earlier generations. However, in most
cases the differences in sensitivity may be caused by
exposure of the 2nd and 3rd generations for longer periods
than the parental generation or during sensitive juvenile
stages (see Case Studies in Supplemental Data S1 for EE2
and Data S2 for TRB). These results suggest the uptake of
some EAS into the egg during its development in the
exposed female parent fish may be important. Whereby,
the egg’s exposure during its maturation inside the female
increases the sensitivity of hatched larvae once the egg is laid
and fertilized.
In mammals, there are a multitude of effects in males and
females seen only in the F1 (offspring) and not in the P0C 2016 The Authors/ieam.1866
296 Integr Environ Assess Manag 13, 2017—JL Parrott et al.(parent) generation including delayed effects, effects on
reproductive life span, etc. (Gray et al. 1994, 1997; Bigsby
et al. 1999; Vidaeff and Sever 2005; Hotchkiss et al. 2007). A
variety of protocols are in use to assess multigenerational
effects in rats and mice including multigeneration,
one-generation, and enhanced one-generation protocols
(examples are the ECHA enhanced one-generation protocols
and the OECD Extended One-Generation Reproductive
Toxicity Study). In addition, the NIEHS NTP uses a different
protocol, they identified as a modified-one-generation test
(NIEHS 2015) (https://ntp.niehs.nih.gov/testing/types/mog/
index.html).
A review by Schwindt (2015) finds some evidence of
EAS-related multigenerational effects in aquatic species,
where exposure of the parent can result in changes in
offspring. However, he also concludes that there appear to
be no clear demonstrations of heritable transgenerational
effects in aquatic species exposed to EAS. Rorije et al. (2011)
found that for 49 of 50 of compounds tested in rat
multigenerational tests, the additional information provided
by the second generation did not influence the chemical
classification and labeling decisions under the European
Chemical Agency guidance (Rorije et al. 2011).
Overall, for EDS, there is little evidence for multigenera-
tional effects beyond the second generation. Slight de-
creases in LOECs are often due to increased exposure from
maternal transfer, in addition to the continued exposure of
the F2 organism. Standardized extended one-generation
tests are now available to assess these potential multigener-
ational effects of EAS so information can be obtained relating
to whether multigenerational effects occur. These character-
istics and considerations apply equally to substances with
other specific or nonspecific modes of action as they are not
unique to EDS.
NONMONOTONIC DOSE RESPONSES
Nonmonotonic dose–responses (NMDRs) are frequently
observed in toxicological experiments. Nonmonotonic
dose–responsesmay originate from various causes (reviewed
in Lagarde et al. 2015) such as: nutritional value of the test
compound for the test organism (e.g., essential metals with a
deficiency, optimum, and toxicity part of the curve); poor
control performance (suboptimal control values, optimal
performance at low concentrations, toxicity at higher
concentrations); hormesis phenomena such as overcompen-
sation or some kind of stimulation (e.g., enzyme induction by
a test compound at low concentrations followed by toxicity at
higher concentrations); metabolism of the test compound
(whereby the metabolite induces a different type of effect
than the parent compound); and chance findings (emphasiz-
ing the need for repeatability and an appropriate number of
replicates and not toowidely spaceddosegroups) etc.Often,
NMDRs can be explained by 2 distinct mechanisms or effect
types operating simultaneously with 1 mechanism dominat-
ing the low concentration response and the other the high
concentration response, the latter frequently is associated
with overt toxicity.Integr Environ Assess Manag 2017:293–301 wileyonlinelibrary.cNonmonotonic dose–responses are not specific to EAS
(Calabrese 2008; EFSA 2013; Beausoleil et al. 2016), but are
found across all types of chemicals in all kinds of test systems
including in vitro and in vivo tests. Nevertheless, there is
concern that, particularly for EDS, the occurrence of NMDRs
might confound the setting of robust NOAELs, thus
compromising the risk assessment. Clearly, for risk
assessment, only the in vivo apical adverse effect NMDRs
would be of interest as in general only adverse effects are
used in risk assessment.
Although most scientists agree that NMDR phenomena
can occur (Ankley and Villeneuve 2015), many contend that
the NMDRs demonstrated to date would not lead to
unidentified hazards or risks for human health and the
environment (van derWoude et al. 2005). Arguments include
statistical insignificance of some NMDR data, erroneous
combinations of different endpoints as a single response,
mischaracterization of oscillatory biochemical and cellular
phenomena that counteract rather than produce adverse
effects, lack of reproducibility, and the inability to explain
more numerous, well-established monotonic relationships
(Witorsch 2002; Kamrin 2007; Rhomberg and Goodman
2012; Fussell et al. 2015). Regardless of this debate, it is clear
that current (eco)-toxicological test methods identify NMDRs
regularly, and therefore it is prudent to develop clear criteria
for identifying NMDRs (Lagarde et al. 2015; Beausoleil et al.
2016) and for assessing dose–response phenomena in
regulatory decision making (Borgert et al. 2015).
Evaluation of NMDRs in the context of endocrine hazard and
risk assessment
Based on the considerations presented above, a scheme is
proposed to evaluate NMDRs for both nonapical (mechanis-
tic) and apical (adverse) endpoints. A flowchart for NMDRs in
the context of endocrine hazard and risk assessment
procedures is presented; one for in vitro mechanistic
and/or in vivo biomarker endpoints and one for adverse
apical endpoints (Figures 1A and 1B, respectively). The
flowcharts consider aspects of reproducibility and biological
plausibility and, for the apical endpoints, if a threshold (i.e.,
NOAEL) can reliably be determined.
If a NMDR is observed for a mechanistic endpoint, the
flowchart (Figure 1A) can be used to identify whether further
investigation of potential downstream effects on apical
endpoints is warranted. For apparent mechanistic NMDRs
that have no plausible biological explanation and are not
reproducible, lower weight is placed on these findings and
testing should proceed without special consideration.
Mechanistic NMDRs that are reproducible, even if not well
understood, may need to be considered in in vivo experi-
ments to detect apical endpoints. There are many examples
of EAS that produce NMDRs in mechanistic but not apical
endpoints, and, therefore, have no impact on the risk
assessment (e.g., propiconazole [Goetz et al. 2009; Skolness
et al. 2013], perchlorate [Li et al. 2011; Petersen et al. 2015],
TRB [Ankley et al. 2003; Ekman et al. 2011], and vinclozolin
[Monosson et al. 1999]).C 2016 The Authorsom/journal/ieam
BA
Figure 1. (A) Proposed flowchart scheme for evaluation of NMDRs for mechanistic endpoints (in vitro and biomarkers). (B) Proposed flowchart scheme for
evaluation of NMDRs for in vivo apical and/or population-relevant endpoints.
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observation of an apparent NMDR in an apical endpoint
and is used to establish whether a threshold can be
determined. Qualitative criteria for identifying NMDRs have
been discussed by Calabrese (2008) and Lagarde et al.
(2015). For apparent apical adverse NMDRs that have no
plausible biological explanation and are not reproducible, a
weight-of-evidence analysis may continue without special
consideration. If the existence of an NMDR is supported by
mechanistic evidence, the study design may be refined to
further characterize the response and to establish whether a
threshold can be determined. An example of a
nonmonotonic apical response to an EAS is the masculini-
zation of genetically female Chinook salmon exposed as
juveniles to 17a-methyltestosterone (MT). With increasing
concentration, a higher proportion of fish developed testes,
culminating in 100% masculinisation at 400mg/L; however,
higher concentrations of MT resulted in decreased propor-
tion of fish with testes and the development of ovaries in up
to 11.8% of fish (Piferrer et al. 1993). The underlying
mechanism for these effects is now understood to be the
biological conversion of MT to 17a-methylestradiol via the
aromatase enzyme (Hornung et al. 2004), which also
explains the observation of NMDR in vitellogenin produc-
tion of juvenile zebrafish exposed to MT ( €Orn et al. 2003).
Another example is the observation that fish exposed to low
doses of EE2 produce more eggs than control groups, and
fish exposed to higher concentrations produce fewer eggs
than control groups (Nash et al. 2004; Pawlowski et al.
2004; Parrott and Blunt 2005). It is plausible that increased
egg production at low concentrations of EE2 is mediated
via stimulation of vitellogenin production in females (Kime
et al. 1999), but it is unclear what mechanism and/or
mechanisms may account for decreased egg production at
higher concentrations of EE2 or whether it is related to maleIntegr Environ Assess Manag 2017:293–301 DOI: 10.1002reproductive pathology. As is the case with many NMDRs,
this could be explained by the overlay of 2 distinct
mechanisms operating simultaneously, with one dominat-
ing at the low and the other at the high concentration. In
such situations, refined studies should be considered to
characterize each mechanism’s dose response separately
and to establish whether a threshold can be determined.
Further studies may also be needed to determine if and
under which circumstances NMDRs such as increased egg
production are adverse effects that should be considered
for risk assessment.
In summary, for nonreproducible NMDRs and plausible
and/or reproducible NMDRs in apical endpoints for which a
threshold can be determined, risk assessment is the
proposed approach. However, if a threshold for an apical
endpoint cannot be determined, hazard assessment may be
the preferred option.
THRESHOLDS
The discussion around thresholds and the existence
thereof has similarity with those around hypotheses: they
cannot be proven, only disproven. Nevertheless, when a
hypothesis holds despite numerous attempts to disprove it, it
becomes part of accepted scientific theory. “Proving” no
effect in an experiment (e.g., determining a NOEL) is based
on a statistical comparison (with usually 5% uncertainty) of the
performance in the treatment groups with that in the control,
and thus it does not necessarily imply zero effect. TheNOEL is
a selected test concentration whereas the mathematical
description of the dose–response curve is often asymptotic
(i.e., no zero response) and merely illustrates the difference
between theory andpractice. Thismeans that by applying the
generally agreed principles of statistical testing in (eco)
toxicology, a threshold can be determined in practice (with
a¼ 0.05).C 2016 The Authors/ieam.1866
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cannot be established for endocrine effects because the
zero-effect level is subject to limits of detection and other
sources of uncertainty (Zoeller and Vandenberg 2015), an
argument that relies on a mathematical definition of
threshold as the lowest dose that produces a nonzero
response (Slob 1999). A related argument is that because
the endocrine system of an individual organism is already
activated above zero response by endogenous hormones
whose concentrations are low and fluctuate widely, small
additions or subtractions of even a single molecule will
exhibit “additivity to background,” producing adverse
effects (Hass et al. 2013). A third argument is that because
the sensitivity and function of the endocrine system
changes with growth and development, and different
endpoints are differentially sensitive to the same
hormone, it would be impossible to define a single
threshold dose for an EAS, even if one existed (Zoeller and
Vandenberg 2015).
Other scientists disagree, pointing to the definition of
threshold as the lowest dose that produces a measurable
physiological effect in an individual organism (Piersma et al.
2011; Rhomberg et al. 2011) and citing contradictions
between this hypothesis and established principles of
endocrine pharmacology and clinical epidemiology, the
mathematical improbability of a single molecule altering
occupancy at receptors, enzymes, or transporters (Borgert
et al. 2013), and mechanistic concepts demonstrable from
systems biology (Zhang et al. 2014).
In the 6 case studies evaluated as part of the SETAC
Pellston Workshop, in nearly all cases threshold determina-
tionwas straightforward. Studies that scored a Klimisch rating
of 1 or 2 described experiments with apical endpoints and
exposure concentration ranges that allowed thresholds to be
resolved for adverse population-relevant effects. Examples
are EE2, TRB, TBT, and propiconazole’s impacts on fish
reproduction (see Case Studies in Supplemental Data S1,
Data S2, Data S3, and Data S4). For certain legislations such
as REACH, defining thresholds is an important aspect of the
process for an EDS. In terms of apical population-relevant
endpoints, determining clear thresholds for endocrine-
mediated adverse effects does not present a barrier to
robust endpoint derivation for risk assessment. Indeed, the
difficulties and uncertainties stated by the references above
apply, not only to EDS, but to all chemicals. In general, the
current methods in risk assessment allow us to tackle most of
these to achieve sound decision making.
Environmental risk assessment is most often concerned
with effects on populations, not individuals (reviewed in
Marty et al. this issue). Resiliencies of populations (Hutchings
2011; Hazlerigg et al. 2012, 2014; Pittman et al. 2013; Debes
et al. 2014) make it easier conceptually to define thresholds
for many EDS in terms of adverse population-level effects.
Several extended tests for EDS are available from the OECD
tool box (discussed below and in more detail by Coady et al.
[this issue]), which in combination with appropriate exposure
concentrations–doses allows robust population-relevantIntegr Environ Assess Manag 2017:293–301 wileyonlinelibrary.cthresholds to be determined. If these criteria for threshold
determination are satisfied, we recommend that the environ-
mental risk assessment process can proceed for an EDS.
IMPORTANCE OF TEST DESIGNS RELATED TO EAS
All the issues highlighted pertain to the ability to derive
robust NOAELs required for sound risk assessment.
Consequently, the availability and adequacy of test
methods is crucial to resolve these uncertainties on a
substance-by-substance basis. The OECD Conceptual
Framework (CF) outlines the available validated tools
(OECD 2012). Once a substance has been confirmed as
an EAS, higher tier testing is typically required to confirm if
the activity translates into an adverse effect, i.e., whether
the substance is an EDS or not. The development of these
tests (e.g., OECD CF levels 4 and 5 or tier II of the USEPA-
EDSP) was largely driven by the perceived need to assess
the potential of endocrine-mediated multigenerational
effects. Validation and demonstration studies highlighted
the fact that shorter designs were preferable, as the
evidence for markedly lower effect levels with additional
generations was not supported by the data (Janer, Hakkert,
Slob et al. 2007; Piersma et al. 2011; Schulz et al. 2014).
Indeed, this trend cannot only be seen in the move away
from a medaka multigeneration test design to an extended
one-generation design (OECD TG 240 and USEPA
MEOGRT 890.2200), but also in the rat extended one-
generation reproduction toxicity study (OECD TG 443). The
extended one generation test designs do assess effects in
the F1 offspring, and the design has focused on increasing
replication of the breeding adult and F1 offspring
assessments, which is analogous to the developments in
the medaka-extended one-generation design. Therefore,
within the tool box there are tests capable of adequately
identifying EAS/EDS, and when necessary, providing robust
NOAELs for risk assessment. These higher tier tests can
capture potential delayed, multigenerational effects and
NMDR if relevant.
However, test methods alone do not cover all elements of
experimental design that should be optimized to address
the substance-specific questions. These issues are
discussed in detail in the companion article by Coady
et al. (this issue). Interpreting the data from these tests also
requires us to mechanistically link effects from different
biological levels (biochemistry, histopathology, individual
morphology, behavior, and reproduction) to conclude on
the mode of action that may lead to adversity. This is no
easy task and will require new tools to better understand
the biological responses and what magnitude of change
can lead to adverse apical effects.
DISCUSSION AND CONCLUSIONS
It is clear that for EDS, it is important to consider delayed
effects and multigenerational effects when deciding which
tests to perform for an environmental risk and/or hazard
assessment. Standardized tests to assess EAS that include
exposures over critical windows and follow organisms forC 2016 The Authorsom/journal/ieam
Uncertainties in Biological Responses—Integr Environ Assess Manag 13, 2017 299sufficient time (to determine whether there are delayed
effects or effects on the next generation) are available for fish,
birds, and mammals in the OECD test battery.
Nonmonotonic dose responses can occur with exposure to
EDSs and other chemicals. These are observed more
frequently in biomarker-type responses (nonapical mecha-
nistic responses) and can often be explained by system
adaptation and compensation in the early phases of
exposure prior to re-establishing biological homeostasis.
Some NMDRs are seen in apical endpoints and may often be
explained by stimulation at low concentrations and toxicity at
higher concentrations or by the existence of different
mechanisms of action at low and high exposure ranges.
However, NMDRs for apical endpoints are less common. If
the apical-effect dose–response curve with the NMDR can be
repeated, explained, and understood, then a robust thresh-
old can be derived. If a threshold cannot be determined, risk
assessment is not recommended.
Similarly, threshold derivation depends on the selection of
appropriate exposure concentrations–doses used in the
appropriate EDS test (from the OECD tool box). When the
appropriate tests and concentration ranges are used,
population-relevant robust thresholds can be derived for
use in environmental risk assessment.
The OECD Conceptual Framework forms the basis of the
toolbox to address the issues highlighted in this article. It
should not be considered a test battery per se. It is not
necessary to have data from all levels to conclude on
potential endocrine disrupting properties of substances. The
tools in the OECD Conceptual Framework should rather be
used selectively to establish an adequate suite of experi-
ments that should be performed to best address the
identified EDS-related questions (e.g., delayed effects,
multigenerational effects, NMDR, etc).
In conclusion, although EDS require detailed ecotoxico-
logical test designs that consider critical windows of
exposure, delayed effects, multigenerational effects, and
sometimes nonmonotonic-dose–response curves, these
factors should not prevent the robust determination of
NOAELs for use in environmental risk assessment.
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